Searchable abstracts of presentations at key conferences in endocrinology

ea0015p345 | Thyroid | SFEBES2008

Fixed and calculated doses of radioiodine achieve similar cure rate for hyperthyroidism

George Jyothis , Matthews David , McIntyre Elizabeth

Background: Radioiodine ablation is an effective curative treatment for hyperthyroidism in virtually all patients with single or multiple doses. The dosage of radioiodine used in the treatment of thyrotoxicosis has varied widely according to local experience and practice. Administration of low doses could lead to inadequate or delayed response, while using larger doses is associated with the risk of increased incidence of hypothyroidism.Introduction: In ...

ea0011p145 | Clinical case reports | ECE2006

Postmenopausal androgen excess: a clinical perspective

Ritchie SA , Collier A , McIntyre M , Connell JMC

We present two cases of postmenopausal, gonadotrophin-dependent androgen excess.Case 1: A 59-year-old postmenopausal female presented with a 4-year history of hirsuitism and male pattern balding. Past medical history included Type II diabetes, hypertension, and polycystic ovarian syndrome. Investigations revealed androgen excess (testosterone 8.9 nmol/l [ref range<2.5], free androgen index 31.8 [ref 0-7], androstenedione 13.7 nmol/l [ref<6.8], DH...

ea0036P33 | (1) | BSPED2014

Improving the clinical pathway for diabetic retinal screening in paediatric diabetes

Chatterjee Sumana , McIntyre Bethannie , Cole Abosede , Burren Christine

Background: Diabetic retinopathy is a frequent cause of vision loss in young adults. NICE guidelines require services to offer annual retinal screening to all diabetic children aged ≥12 years. A local 2009–2010 audit identified 57% underwent screening but only 16% had results documented with the paediatric diabetes service, both areas requiring improvement. In 2011, the paediatric diabetes service formulated a standard operating procedure with the eye-screening prog...

ea0004oc30 | Neuroendocrinology and diabetes | SFE2002

INVESTIGATION OF IMPAIRED INSULIN ACTION IN CULTURED SKELETAL MUSCLE FROM TYPE 2 DIABETES MELLITUS PATIENTS

McIntyre E , Halse R , Yeaman S , Walker M

Impaired insulin action is a characteristic feature of type 2 diabetes and skeletal muscle is the principal tissue for peripheral glucose disposal. Aims: To determine if after prolonged culture human muscle cells from characterised type 2 diabetes patients have defects of insulin action compared to controls. Design: After attaining local Ethical Committee approval six compliant type 2 diabetic patients with severe clinical insulin resistance, on greater than 100 units of insul...

ea0004dp13 | Diabetes, metabolism and cardiovascular | SFE2002

INVESTIGATION OF IMPAIRED INSULIN ACTION IN CULTURED SKELETAL MUSCLE FROM TYPE 2 DIABETES MELLITUS PATIENTS

McIntyre E , Halse R , Yeaman S , Walker M

Impaired insulin action is a characteristic feature of type 2 diabetes and skeletal muscle is the principal tissue for peripheral glucose disposal. Aims: To determine if after prolonged culture human muscle cells from characterised type 2 diabetes patients have defects of insulin action compared to controls. Design: After attaining local Ethical Committee approval six compliant type 2 diabetic patients with severe clinical insulin resistance, on greater than 100 units of insul...

ea0081ep625 | General Endocrinology | ECE2022

The development of a GLP protocol for the measurement of 17β-estradiol and testosterone in the H295R steroidogenesis assay, Test No 456

Murray Carol , McIntyre Angela , McKeever Connor , White Rebecca , McBrinn Rachel , Light Victoria , Brown Susan , Robinson Aron , Clark Graeme , Bingham Tilly

Regulators are concerned about the potential for environmental chemicals such as agrochemicals and their metabolites to perturb hormone systems. This has led to recommendations for the testing of potential endocrine disrupting chemicals1. The Steroidogenesis H295R assay is an in vitro cell model used to investigate compound effects on steroid hormone biosynthesis, specifically 17β-estradiol (E2) and testosterone (T). The human H295R adreno-carcinoma ce...

ea0077p243 | Reproductive Endocrinology | SFEBES2021

The effect of exogenous kisspeptin administration in a novel mouse model of hypothalamic amenorrhoea

Shrewsbury Jed V , Ng Kah-Yan , McIntyre Caitlin , Li Xiao Feng , Phylactou Maria , O’Byrne Kevin T , Abbara Ali , Dhillo Waljit S , Owen Bryn M

Kisspeptin is integral to hypothalamo-pituitary-gonadal (HPG) axis function and overall fertility. Functional deficiency of GnRH/lH secretion in the central reproductive disease, hypothalamic amenorrhoea (HA), indicates diminished kisspeptin signalling. Clinical trials have shown kisspeptin to be a viable therapeutic intervention. However, repeated administration led to the development of tachyphylaxis and so is likely a problem for future implementation. Indeed, elevated LH r...

ea0092ps1-08-01 | Translational 1 | ETA2023

Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI resistant metastatic thyroid cancers

Rehman Syed Abdul , Gorona Aakash , Nohr Erik , Kat Yuan Xiaoli , Amin Parthiv , Ghaznavi Sana , Lamb Debbie , McIntyre John , Eszlinger Markus , Paschke Ralf

Introduction: Two-thirds of metastatic differentiated thyroid cancer (DTC) patients have RAI-resistant disease, resulting in poor prognosis and high disease-related mortality. Current studies of individualized therapy with different MAPK inhibitors report restoring RAI-avidity in 50 – 70% of BRAF and RAS mutated and thyroid cancers with no detected driver mutation. Five recent case reports of rare NTRK and RET-PTC fusion-positive metast...